FindTrial
Sign In

Hematological and biochemical abnormalities parameters in the severity of COVID-19

The abnormalities in hematological and biochemical parameters and correlation evaluation between laboratory examinations and the severity of COVID-19.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028523
Enrollment
200
Registered
2020-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B998- Other infectious disease

Interventions

None listed

Sponsors

Parumkhswami Medicall College and Shree Krishna Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with positive RT-PCR for COVID-19

Exclusion criteria

Exclusion criteria: Patients with positive serology without conformed by RT-PCR for COVID-19.

Design outcomes

Primary

MeasureTime frame
To investigate the ability of C-reactive protein (CRP), ferritin, interleukin-6 (IL-6), and procalcitonin (PCT) to predict mild and severe cases of COVID-19.Timepoint: Three month—

Secondary

MeasureTime frame
To evaluate the accuracy of others laboratory parameters (CBC, Differential Count, Thrombin Time, D DIMER and Lactate Dehydrogenase) in predicting cases with positive RT-PCR for COVID-19.Timepoint: Three Month—

Countries

India

Contacts

Public ContactDr Abdulrahman Amer

Pramukhswami Medical College, Karamsad

hiteshns@charutarhealth.org9825357205

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026